Teleflex (TFX) Tops Q2 EPS by 6c, Revenues Miss; Offers FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Teleflex (TFX) PT Lowered to $279 at Needham & Company
August 3, 2018 6:46 AM EDTNeedham & Company lowered its price target on Teleflex (NYSE: TFX) to $279.00 (from $298.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "TFX's 2Q18 revenue missed while EPS beat consensus. Organic revenue growth (adjusted for selling days and a surgical product line exit)... More



